- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06064604
Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke
Clinical Trial: Powered Hip & Ankle Exoskeletons for Stroke Survivors With Gait Impairment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will serve as their own control in this study. This study will be divided into 2 sessions that will occur on 2 separate days: 1) Hip Exoskeleton session and 2) Ankle Exoskeleton session. In each session, subjects will undergo two conditions in which they complete the outcomes measures 1) while wearing the exoskeleton and 2) in a baseline condition without the exoskeleton. Order of condition and session will be randomized.
Prior to the exoskeleton condition, subjects will be allowed time to acclimate to the device during a walking session on the treadmill. Subjects will proceed to complete a timed indoor community circuit in which they will complete a 10 meter walk test over an instrumented gait mat which will record information about their walking. The indoor community circuit may also include turning, walking up/down a ramp and walking up/down a staircase.
Subjects will then proceed to complete an outdoor 6-minute walk test (6MWT) on a pre-defined course on Georgia Tech's campus. When outdoors, participants will be guarded with a gait belt and a researcher who will walk alongside them throughout the experiment to reduce the risk for a fall. Borg Rating of Perceived Exertion (RPE) and Physiological Cost Index (PCI) will be assessed and calculated following completion of the 6MWT. Following each condition, subjects will then sit, rest and complete a suite of patient reported outcomes in which the investigators will ask questions about their perception of their performance with and without the device; investigators will also ask them questions about the device. Following completion of surveys, subjects will repeat the same outcomes for the other condition- either the baseline condition or the exoskeleton condition, depending on the initial randomization.
Throughout the procedures, subjects will be monitored for fatigue and asked if they need a break. They will be encouraged to voice any concerns (discomfort, fatigue or otherwise) to the research personnel, who will respond accordingly. Participants will be guarded with a gait belt or harness to reduce the risk of falls while participating in the protocol.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aaron Young, PhD
- Phone Number: 404-385-5306
- Email: aaron.young@me.gatech.edu
Study Contact Backup
- Name: Greg Sawicki, PhD
- Phone Number: 404-385-5706
- Email: greg.sawicki@me.gatech.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30332
- Exoskeleton and Prosthetic Intelligent Controls Lab
-
Contact:
- Aaron Young, Ph.D.
- Phone Number: 404-385-5306
- Email: aaron.young@me.gatech.edu
-
Sub-Investigator:
- Kinsey R Herrin, MSPO, C/LPO
-
Contact:
- Greg Sawicki, PhD
- Phone Number: 470-578-7600
- Email: greg.sawicki@me.gatech.edu
-
Principal Investigator:
- Aaron Young, PhD
-
Principal Investigator:
- Greg Sawicki, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Chronic stroke survivors (at least 6 months post stroke)
- Age 18-85 years of age with a neurological condition or gait impairment from stroke capable of participating in the study procedures (as per participant report)
- Ability to sit unsupported for minimum of 30 seconds.
- Ability to walk without support (a rail as needed), with a walking speed of at least 0.4 m/s (limited community ambulatory speed);
- Must be able to walk for at least 6 minutes for each trial;
- Willingness and ability to participate over a 1-4 hour experiment, with breaks enforced regularly and as needed;
- Ability to transfer (sit-to-stand and stand-to-sit) with no external support (arm rests support allowed);
- Ability to ambulate over small slopes (3 degrees) and a few steps (6 steps).
Exclusion Criteria:
- Any loss of sensation in the legs
- A complete spinal cord injury,
- History of concussion in the last 6 months (per participant report),
- History of any severe cardiovascular conditions, severe arthritis, or orthopedic problems that limit lower body movement,
- Presence of other neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), dementia,
- History of head trauma which is not fully resolved (per participant report),
- Lower extremity amputation,
- Non-healing ulcers of a lower extremity,
- Renal dialysis or end state liver disease,
- Legal blindness or severe visual impairment.
- Use of a pacemaker or
- Presence of metal implants in the head region,
- Have uncontrolled seizures.
- Lastly, if participants are participating in another clinical study and/or a participant's physical condition is limited to do different tasks, in the opinion of the Principal Investigator (PI), would likely affect the study outcome or confound the results, participants will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Stroke Survivors
This study will be divided into 2 sessions that will occur on 2 separate days: 1) Hip Exoskeleton session and 2) Ankle Exoskeleton session. In each session, subjects will undergo two conditions in which they complete the outcomes measures 1) while wearing the exoskeleton and 2) in a baseline condition without the exoskeleton. Order of condition and session will be randomized. Prior to the exoskeleton condition, subjects will be allowed time to acclimate to the device during a walking session on the treadmill. Subjects will complete several timed walking tests both indoors and outdoors. Measurements of energy expenditure may also be recorded along with patient reported outcomes data to assess participant perception of their performance with and without the devices. |
The stroke survivors will serve as their own control group.
The participants will complete the required tasks without an exoskeleton device.
Other Names:
The Georgia Tech Hip Exo is a wearable robotic device for hip extension/flexion assistance.
This device will be used to study the lower limb movement and how to effectively assist users.
It makes use of a responsive controller that considers information such as joint angles to understand the user's state and assists with the appropriate level of power accordingly.
Other Names:
The Dephy Exoboot is a lower limb exoskeleton which attaches to the user below the knee through a cuff at the proximal calf and a provided shoe.
This investigational device is used to make it easier for able-bodied and impaired individuals to walk and run under a variety of conditions.
The exoskeleton provides assistance at the ankle joint during movement.
The purpose is to assist the user in lower limb movements such as ground level walking, climbing stairs/ramps, and sit-to-stand.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
10 meter walk test (10MWT)
Time Frame: 2 weeks
|
This measures the individual's preferred overground walking speed, indicating their physical capability with an exoskeleton device
|
2 weeks
|
6-minute walk test (6MWT)
Time Frame: 2 weeks
|
This measures the individual's walking distance over 6 minutes to assess aerobic endurance.
|
2 weeks
|
Physiological Cost Index
Time Frame: 2 weeks
|
This measures the individual's oxygen consumption while walking.
It will be calculated using a 6-minute walk test (6MWT) and heart rate.
|
2 weeks
|
Borg Rating of Perceived Exertion (RPE)
Time Frame: 2 weeks
|
This measures the individual's perceived physical activity intensity level, indicating how hard the individuals believes their body is working to conduct walking tasks with and without the exoskeleton devices.
|
2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aaron Young, PhD, Georgia Institute of Technology
- Principal Investigator: Greg Sawicki, Georgia Institute of Technology
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H23332
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted